Long‐term outcomes of relapsed/refractory double‐hit lymphoma (r/r DHL) treated with CD19/22 CAR T‐cell cocktail therapy-Reference-Cited by-同舟云学术

Long‐term outcomes of relapsed/refractory double‐hit lymphoma (r/r DHL) treated with CD19/22 CAR T‐cell cocktail therapy

Published:2020-09 Issue:5 Volume:10 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Wei Jia¹²^ORCID,Mao Zekai¹²,Wang Na¹²,Huang Lifang¹²,Cao Yang¹²,Sun Weimin¹²,Long Xiaolu¹²,Tan Jiaqi¹²,Li Chunrui¹²^ORCID,Xiao Yi¹²,Gu Chaojiang³⁴,Zhang Shangkun⁴,Zhang Yicheng¹²,Zhang Tongcun³⁴,Zhou Jianfeng¹²^ORCID,Huang Liang¹²^ORCID

Affiliation:

1. Department of Hematology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China

2. Immunotherapy Research Center for Hematologic Diseases of Hubei Province Wuhan Hubei China

3. College of Life Science and Health Wuhan University of Science and Technology Wuhan Hubei China

4. Wuhan Bio‐Raid Biotechnology Co., Ltd Wuhan Hubei China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.176

Reference10 articles.

1. Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies

2. High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology

3. Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

4. Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma

5. MYC + diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T cell combination therapies in hematologic malignancies;Experimental Hematology & Oncology;2024-07-18

2. Combination of chidamide and PD-1 blockade in Refractory/Relapsed aggressive large B-cell lymphomas with high risk of failing CAR-T therapy;International Immunopharmacology;2024-05

3. Recent advances in CAR‐T cell therapy for acute myeloid leukaemia;Journal of Cellular and Molecular Medicine;2024-05

4. Stem Cell Transplantation in Adult Lymphoma Patients;Comprehensive Hematology and Stem Cell Research;2024

5. Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Chinese experience;Haematologica;2023-02-16